T1	Treatment 29 73	MEC (methotrexate, epirubicin and cisplatin)
T2	Treatment 163 166	MEC
T3	Treatment 171 231	M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
T4	Treatment 396 399	MEC
T5	Treatment 403 408	M-VAC
T6	Treatment 598 878	methotrexate, epirubicin and cisplatin chemotherapy group (arm 1: S-MEC therapy; n = 29), a dose-intensified MEC therapy combined with G-CSF group (arm 2: I-MEC therapy; n = 30) or a methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy (arm 3: M-VAC therapy; n = 30).
T7	Treatment 1213 1226	S-MEC therapy
T8	Treatment 1248 1253	I-MEC
T9	Treatment 1324 1337	S-MEC therapy
T10	Treatment 1356 1361	I-MEC
T11	Treatment 1391 1396	M-VAC
T12	Treatment 1429 1434	I-MEC
T13	Treatment 1483 1488	M-VAC
T14	Treatment 1559 1564	I-MEC
T15	Treatment 1647 1658	MEC therapy
